Semaglutide First-Month vs Renewal Price: The Intro-Rate Trap
Released · Last reviewed
Many semaglutide programs advertise a low first-month price ($99) that reverts to a much higher renewal ($299). Compare providers on renewal price and effective monthly cost, not the intro rate.
- Intro rates ($99 first month) often revert to much higher renewals ($299+).
- The renewal price is your real ongoing cost; the intro is a one-time discount.
- First-month savings are quickly absorbed by higher ongoing pricing.
- Always compare providers on renewal price and effective monthly cost.
The intro-rate trap
A program advertising “$99 first month” is quoting a promotion, not your ongoing cost. Many revert to $199, $299, or more on refill. Because most patients stay on semaglutide for months or longer, the renewal price — not the intro — determines what you actually spend.
The first-month discount is real but small in context: a $70 to $140 saving that is quickly absorbed by higher ongoing pricing over a year of treatment.
The real math
Compare two programs: one at $99 first month then $299 renewal, another at $145 flat. Over a year, the first costs $99 plus eleven months at $299, or $3,388. The flat program costs twelve months at $145, or $1,740. The intro rate made the more expensive program look cheaper.
This is why the renewal price is the number that matters. A low intro paired with a high renewal is often more expensive over any realistic treatment period than a modest flat rate.
| Program | First month | Renewal | Annual |
|---|---|---|---|
| Program A | $99 | $299 | $3,388 |
| Program B (flat) | $145 | $145 | $1,740 |
| Program C | $129 | $199 | $2,318 |
How to spot it
The tell is language: “starting at,” “first month,” “introductory,” or a price with an asterisk. Ask directly: what is the price on my second and subsequent months, and is it the same for new and continuing patients. A provider that answers clearly is easier to trust than one that reveals the renewal only at checkout.
Promotional pricing is not inherently deceptive, but it becomes a trap when the renewal is hidden or dramatically higher.
| Phrase | What it usually means |
|---|---|
| 'Starting at' | Lowest dose or longest commitment |
| 'First month' | Promotional, reverts on refill |
| 'Introductory' | Temporary price |
Comparing honestly
Reduce every program to effective monthly cost over your expected treatment period, using the renewal price for months after the first. This normalizes intro promotions and makes programs directly comparable. Our affordability methodology applies exactly this approach.
The lowest intro price rarely wins once you account for renewals. The lowest renewal and effective cost is what protects your budget over the months you will actually be on treatment.
Frequently asked questions
Why did my semaglutide price go up after the first month?
You were likely on an introductory rate that reverted to the standard renewal price. Always confirm the renewal before enrolling.
How do I compare intro pricing fairly?
Use the renewal price for all months after the first and compute effective monthly cost over your expected treatment period.
Are intro rates a scam?
Not inherently, but they become a trap when the renewal is hidden or much higher. Compare on renewal price, not the headline.
Sources
- FDA — human drug compounding and GLP-1 status.
- Provider pricing and renewal terms, captured September 2026.
- Evidence ledger: evidence-ledger.csv.
The numbers behind this page
The semaglutide price range, stated precisely
Standard-dose compounded semaglutide runs $49 to $279 a month across the 22 programmes we priced on October 15, 2026, with a median of $99. The spread is $230 a month, or $2,760 across a year, for a molecule that is chemically identical in every case.
The lowest standing month-to-month prices with no membership are Mondae at $87 and Eden at $99; lower stickers come with a sale, a prepaid year or a membership. Half the programmes sit below $99 and half above it, which makes the median a more useful reference point than the lowest sticker when judging a quote.
Two programmes printed a semaglutide microdose price on October 15, 2026 (Shed from $149, Noom Med $179); NexLife's microdose semaglutide has cost the same as its standard plan since November 8, 2026 ($109 a month month-to-month). Those figures are excluded from the range above. A microdose sits below every dose studied in the pivotal trials, so including it would compare two different things and would make the market look cheaper than it is at a therapeutic dose.
Three structural facts move a bill more than the headline rate. Whether the price is flat across covered doses or rises as you titrate. Whether a membership is billed separately from medication. And whether the advertised figure requires prepaying six or twelve months, which lowers the monthly number by transferring risk to you at exactly the point you are least certain you will continue.
How semaglutide is kept current
On October 15, 2026, compounded semaglutide ran $49 to $279 a month across the 22 programmes we priced. Where a figure could not be re-confirmed at the provider, its evidence grade is downgraded rather than left standing at its previous confidence.
Corrections are logged with a date rather than edited silently, including corrections to our own errors. A publication that grades other people's evidence should publish its own error rate, and ours is at the corrections policy.
No provider pays for placement, position or inclusion here. Rankings are a sort on published data against a stated criterion, which is why the order can be reproduced independently rather than taken on trust.
Reading the price against the market
Why the spread is this wide
Standard-dose semaglutide spans $49 to $279 a month across the 22 programmes we priced on October 15, 2026, a spread of $230.
The molecule is chemically identical across every programme in the range. The $230 a month between the lowest and highest all-in semaglutide prices we read on October 15, 2026 ($49 and $279) is not a difference in medicine. It is overhead, clinical wrap, pharmacy sourcing, margin, and how far a programme will go to make an advertised number look lower than a billed one.
Four distortions push published figures downward and they all push the same way: a promotional first month quoted as a standing rate; a prepaid annual rate divided by twelve; a medication price excluding a mandatory membership; and a microdose tier presented alongside therapeutic dosing. Each is individually defensible and together they compound.
Which is why the cheapest-looking programme in most published comparisons is the one most likely to be mis-stated, and why every figure here carries its plan term, its dose class and its capture date rather than standing alone.
Questions this page answers
Why is microdosed semaglutide cheaper?
Because it is less medicine. On October 15, 2026, Shed listed a semaglutide microdose from $149 a month and Noom Med at $179 after a $79 start. A microdose sits below every dose studied in the pivotal trials, so it is not a cheaper route to the result those trials measured.
What does compounded semaglutide cost per month in October 2026?
As of October 15, 2026, the 22 compounded semaglutide programs we could price on their own pages charge between $49 and $279 a month at their lowest all-in rate, with a median of $99, counting any required membership and the cheapest plan term each program prints. The low end is made of sale and "as low as" prices: WellMedr's fall sale and NextMeds both start at $49. Standing month-to-month rates with no membership start at $87 (Mondae) and $99 (Eden). Compounded semaglutide is not FDA-approved.
What does compounded semaglutide normally cost?
$49 to $279 a month at the lowest all-in rate across the 22 programs we priced on October 15, 2026, with a median of $99. Half the programs sit either side of that median, which makes it a better reference than the lowest sticker when you judge a quote.
Does compounded semaglutide cost more at higher doses?
At the programmes listed here the monthly price is flat across covered doses; what changes the figure is the plan term, not the dose. Dose-tiered pricing does exist elsewhere in this market, so confirm at checkout.